148 related articles for article (PubMed ID: 12759155)
1. Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population.
Tournier M; Sorbara F; Gindre C; Swendsen JD; Verdoux H
Psychiatry Res; 2003 May; 118(1):1-8. PubMed ID: 12759155
[TBL] [Abstract][Full Text] [Related]
2. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.
Verdoux H; Gindre C; Sorbara F; Tournier M; Swendsen JD
Psychol Med; 2003 Jan; 33(1):23-32. PubMed ID: 12537033
[TBL] [Abstract][Full Text] [Related]
3. The association between cannabis use and anxiety disorders: Results from a population-based representative sample.
Feingold D; Weiser M; Rehm J; Lev-Ran S
Eur Neuropsychopharmacol; 2016 Mar; 26(3):493-505. PubMed ID: 26775742
[TBL] [Abstract][Full Text] [Related]
4. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
5. Cannabis and anxiety and depression in young adults: a large prospective study.
Hayatbakhsh MR; Najman JM; Jamrozik K; Mamun AA; Alati R; Bor W
J Am Acad Child Adolesc Psychiatry; 2007 Mar; 46(3):408-417. PubMed ID: 17314727
[TBL] [Abstract][Full Text] [Related]
6. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
7. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.
van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
Drug Alcohol Depend; 2013 Dec; 133(2):352-9. PubMed ID: 23886472
[TBL] [Abstract][Full Text] [Related]
8. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
[TBL] [Abstract][Full Text] [Related]
9. Cannabis use and mental health-related quality of life among individuals with anxiety disorders.
Lev-Ran S; Le Foll B; McKenzie K; Rehm J
J Anxiety Disord; 2012 Dec; 26(8):799-810. PubMed ID: 23023160
[TBL] [Abstract][Full Text] [Related]
10. [Comorbidity in 207 cannabis users in a specific outpatient setting].
Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
[TBL] [Abstract][Full Text] [Related]
11. Cannabis use and mental health in young people: cohort study.
Patton GC; Coffey C; Carlin JB; Degenhardt L; Lynskey M; Hall W
BMJ; 2002 Nov; 325(7374):1195-8. PubMed ID: 12446533
[TBL] [Abstract][Full Text] [Related]
12. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?
van Laar M; van Dorsselaer S; Monshouwer K; de Graaf R
Addiction; 2007 Aug; 102(8):1251-60. PubMed ID: 17624975
[TBL] [Abstract][Full Text] [Related]
13. Reasons for cannabis use in psychosis.
Schofield D; Tennant C; Nash L; Degenhardt L; Cornish A; Hobbs C; Brennan G
Aust N Z J Psychiatry; 2006; 40(6-7):570-4. PubMed ID: 16756582
[TBL] [Abstract][Full Text] [Related]
14. [Impact of DSM-5: Application and Problems Based on Clinical and Research Viewpoints on Anxiety Disorders].
Shioiri T
Seishin Shinkeigaku Zasshi; 2015; 117(10):851-61. PubMed ID: 26827411
[TBL] [Abstract][Full Text] [Related]
15. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood.
Degenhardt L; Coffey C; Romaniuk H; Swift W; Carlin JB; Hall WD; Patton GC
Addiction; 2013 Jan; 108(1):124-33. PubMed ID: 22775447
[TBL] [Abstract][Full Text] [Related]
16. Two-year course trajectories of anxiety disorders: do DSM classifications matter?
Batelaan NM; Rhebergen D; Spinhoven P; van Balkom AJ; Penninx BW
J Clin Psychiatry; 2014 Sep; 75(9):985-93. PubMed ID: 24912140
[TBL] [Abstract][Full Text] [Related]
17. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the proposed DSM-5 cannabis use disorder criteria using Australian national survey data.
Mewton L; Slade T; Teesson M
J Stud Alcohol Drugs; 2013 Jul; 74(4):614-21. PubMed ID: 23739026
[TBL] [Abstract][Full Text] [Related]
19. Adverse mental health effects of cannabis use in two indigenous communities in Arnhem Land, Northern Territory, Australia: exploratory study.
Clough AR; d'Abbs P; Cairney S; Gray D; Maruff P; Parker R; O'Reilly B
Aust N Z J Psychiatry; 2005 Jul; 39(7):612-20. PubMed ID: 15996143
[TBL] [Abstract][Full Text] [Related]
20. Co-morbidity of select anxiety, affective, and psychotic disorders with cannabis dependence in Southwest California Indians.
Gilder DA; Lau P; Dixon M; Corey L; Phillips E; Ehlers CL
J Addict Dis; 2006; 25(4):67-79. PubMed ID: 17088227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
